Skip to NavigationSkip to content

EFPIA names first female Director General

Published on: 27/02/17

Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as its new Director General.

Moll currently serves as the Secretary General of the European Association for Bioindustries (EuropaBio), a position she has held for six years, and has also served the European Commission and the Italian Biotech Industry Association.

She is due to step into the role in April this year, when she will become the company’s first ever female Director General. Eric Cornut, who stepped in to carry the vacancy left by Richard Bergström last year, will fill the role on an interim basis until that time.

Joe Jimenez, Novartis CEO and President of EFPIA commented on Moll’s appointment: “Nathalie has an excellent track record of leadership and engagement across the life science sector. We are confident she is the right person to lead EFPIA, working with stakeholders to address the challenges faced by healthcare systems in Europe.” 

Moll herself remarked: “I am delighted to be joining EFPIA at a time when pharmaceutical innovation is having such a dramatic effect on the lives of patients across Europe. I look forward to working with EFPIA Members, staff and the wider research, healthcare and policy community to foster an environment that supports continued innovation and drives better outcomes for patients.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches